Business context and reporting period
Bladex (Banco Latinoamericano de Comercio Exterior, S.A.; NYSE: BLX) filed this Form 20-F for the fiscal year ended December 31, 2023. It is a Panama-based multinational bank focused on trade finance and regional integration in Latin America and the Caribbean. The filing reports annual results, not a standalone 2023 fourth-quarter income statement. Financial statements are prepared under IFRS as issued by the IASB, in U.S. dollars.
Financial performance and position
| Metric | 2023 | 2022 | Change |
|---|---|---|---|
| Total revenue | $266.1 million | $166.7 million | +60% |
| Net interest income | $233.2 million | $148.0 million | +58% |
| Profit for the year | $166.2 million | $92.0 million | +81% |
| Basic and diluted EPS | $4.55 | $2.54 | +$2.01 |
| Net interest margin / spread | 2.49% / 1.84% | 1.71% / 1.39% | Both increased |
| Operating expenses | $72.5 million | $55.1 million | +32% |
| Provision for credit losses | $27.5 million | $19.5 million | +41% |
- Drivers: Management attributed stronger earnings mainly to wider lending spreads, higher market rates, increased average credit balances, and higher letter-of-credit and structuring/syndication fees. Net interest income benefited by about $84 million from rate effects. Higher personnel costs and performance-based compensation contributed to expense growth.
- Returns and efficiency: Return on average equity rose to 14.68% from 8.95%; return on average assets rose to 1.69% from 1.03%. The efficiency ratio improved to 27.2% from 33.1%.
- Portfolio: Credit Portfolio grew 9% to $9.532 billion; Commercial Portfolio grew 11% to $8.521 billion. Loans at amortized cost reached $7.196 billion, up 6%.
- Asset quality: Credit-impaired loans fell to $10 million, or 0.14% of the Loan Portfolio, from $30 million, or 0.45%. However, Stage 2 loans rose to $307 million from $99 million, and the filing cites increased provisions on exposures with heightened credit risk. The Bank wrote off $21.1 million of loans and $7.0 million of investment securities during 2023. Total expected-credit-loss allowance was $66.1 million, 0.69% of Credit Portfolio, versus $66.8 million, 0.77%, in 2022.
- Balance sheet and funding: Total assets rose 16% to $10.744 billion; equity rose 13% to $1.204 billion. Deposits increased 38% to $4.408 billion, while borrowings and debt, net, declined 1% to $4.352 billion. Deposits represented 48.6% of interest-bearing funding, versus 40.3% a year earlier.
- Liquidity: Liquid assets were $1.999 billion, up from $1.269 billion. The Liquidity Coverage Ratio was 205.8%, compared with 167.5%, against a stated 100% minimum. Cash and cash equivalents at year-end were $1.987 billion; the balance-sheet line “cash and due from banks” was $2.047 billion.
- Cash flow: Net cash provided by operating activities was $1.062 billion, compared with $770 million used in 2022, substantially reflecting a $1.217 billion increase in deposits. Investing activities used $12.8 million; financing activities used $253.2 million, including $36.3 million of dividends paid.
- Capital and debt: Tier 1 capital ratio under Basel III IRB was 15.4%, versus 15.3%; Panama regulatory capital adequacy ratio was 13.6%, versus 13.2%. Total equity to assets was 11.2%, and regulatory leverage ratio was 9.7%. Ratings were investment grade with stable outlooks: Fitch BBB/F2, Moody’s Baa2/P-2, and S&P BBB/A-2. The Bank reported compliance with borrowing covenants.
Material changes versus the prior comparable period
- Revenue, profit, EPS, net interest margin and return on equity increased materially, primarily as higher rates and expanded lending volumes improved interest income and spreads.
- Fee and commission income increased 64% to $32.5 million, led by letters of credit and structured financing activity.
- Credit Portfolio growth was accompanied by higher annual credit-loss provisions and a sharp increase in Stage 2 loan exposures. Impaired balances declined partly because of a large write-off, so the lower reported impaired-loan balance should be considered alongside charge-offs and migration into Stage 2.
- Funding shifted toward deposits: year-end deposits grew, while short-term borrowings and debt declined. Funding costs nevertheless rose; the average rate paid on interest-bearing liabilities increased to 5.30% from 2.39%.
- Treasury segment profit improved to $12.7 million from a $5.6 million loss; Commercial segment profit increased to $153.4 million from $97.6 million.
Outlook, commentary, risks and unusual items
- Outlook: The filing provides no quantified earnings or revenue guidance. Management’s 2022–2026 strategy emphasizes client and product expansion, diversified lending, stronger origination and cross-selling, process efficiency, digitization and technology investment. It expects to focus on top-tier regional financial institutions and corporations and to broaden trade-related offerings.
- Macro and concentration risks: Management identifies regional economic slowdown, inflation, high financing costs, currency depreciation, commodity volatility, weaker trade flows and political uncertainty as risks. Credit is concentrated in Latin America; five countries represented 49% of Credit Portfolio at year-end. Oil and gas represented 19% of the Loan Portfolio; agribusiness represented 3%.
- Liquidity and funding risks: Deposits are uninsured and concentrated, including 39% from central banks or their designees and 33% from the five largest depositors. The Bank does not accept retail deposits. It cites dependence on continued access to institutional deposits, correspondent banks and debt markets.
- Other risks: The filing highlights interest-rate and market risk, credit-loss model uncertainty, sanctions and AML compliance, Panama’s regulatory and tax-list status, cyber and third-party technology risks, and climate and natural-disaster exposure. Panama exited FATF increased monitoring in October 2023; the European Commission removed it from its high-risk AML list in March 2024, while Panama was again included on the EU tax non-cooperative list in February 2024.
- Unusual items and subsequent events: 2023 included $21.1 million in loan write-offs, $7.0 million in investment-security write-offs, and a $3.9 million loss on sales of amortized-cost securities, partly offset by derivative and foreign-currency gains. The Board authorized a share repurchase program of up to $50 million in February 2024. The filing says 2023 cash dividends declared totaled $1.25 per share; a $0.50 fourth-quarter dividend was paid in March 2024.
- Assurance: KPMG issued unqualified opinions on the IFRS financial statements and internal control over financial reporting. Management concluded disclosure controls and internal control were effective as of year-end. The Bank reported no significant litigation and no critical system failures, data loss or cyberattacks in 2023.
Important facts for investors to verify
- Review whether higher rates and lending spreads can sustain earnings as funding costs and market rates change; 2023’s earnings growth was substantially rate-driven.
- Track Stage 2 exposures, future migrations to Stage 3, charge-offs, recoveries and allowance adequacy—not only the decline in impaired loans.
- Assess deposit concentration and the resilience of liquidity under withdrawals or reduced access to institutional funding; distinguish cash equivalents from the broader cash-and-bank balance.
- Monitor country, borrower and sector concentrations, especially regional exposures and oil-and-gas lending, alongside trade and commodity developments.
- Confirm dividend declarations and payments, the scope and execution of the $50 million repurchase authorization, and capital impacts.
- Read the audited financial statements and notes for the credit-loss assumptions, derivative positions, pledged securities, debt maturities and any subsequent developments.